President Trump signed Executive Order 14370 requiring the DEA to expedite the rescheduling of cannabis. On 22 April 2026 the acting attorney general ordered medical cannabis products moved to Schedule III.[1]
Listed for context. No score change is recorded for United States here.
References
Checked. The date and the event were compared with a source that was read.